312 related articles for article (PubMed ID: 23780952)
1. Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.
Chen CL; Young SH; Gan HH; Singh R; Lao AY; Baroque AC; Chang HM; Hiyadan JH; Chua CL; Advincula JM; Muengtaweepongsa S; Chan BP; de Silva HA; Towanabut S; Suwanwela NC; Poungvarin N; Chankrachang S; Wong KS; Eow GB; Navarro JC; Venketasubramanian N; Lee CF; Bousser MG;
Stroke; 2013 Aug; 44(8):2093-100. PubMed ID: 23780952
[TBL] [Abstract][Full Text] [Related]
2. CHIMES-I: sub-group analyzes of the effects of NeuroAiD according to baseline brain imaging characteristics among patients randomized in the CHIMES study.
Navarro JC; Chen CL; Lagamayo PD; Geslani MB; Eow GB; Poungvarin N; de Silva A; Wong LK; Venketasubramanian N;
Int J Stroke; 2013 Aug; 8(6):491-4. PubMed ID: 23506216
[TBL] [Abstract][Full Text] [Related]
3. Chinese medicine NeuroAiD efficacy stroke recovery-extension study (CHIMES-E study): an observational multicenter study to investigate the longer-term efficacy of NeuroAiD in stroke recovery.
Venketasubramanian N; Young S; Tay SS; Chang HM; Umapathi T; Chan B; de Silva A; Wong L; Navarro J; Zhao YD; Tan SB; Chen C
Cerebrovasc Dis; 2013; 35 Suppl 1():18-22. PubMed ID: 23548915
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES Study).
Venketasubramanian N; Chen CL; Gan RN; Chan BP; Chang HM; Tan SB; Picard D; Navarro JC; Baroque AC; Poungvarin N; Donnan GA; Bousser MG;
Int J Stroke; 2009 Feb; 4(1):54-60. PubMed ID: 19236501
[TBL] [Abstract][Full Text] [Related]
5. CHInese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study (CHIMES-E): A Multicenter Study of Long-Term Efficacy.
Venketasubramanian N; Young SH; Tay SS; Umapathi T; Lao AY; Gan HH; Baroque AC; Navarro JC; Chang HM; Advincula JM; Muengtaweepongsa S; Chan BP; Chua CL; Wijekoon N; de Silva HA; Hiyadan JH; Suwanwela NC; Wong KS; Poungvarin N; Eow GB; Lee CF; Chen CL;
Cerebrovasc Dis; 2015; 39(5-6):309-18. PubMed ID: 25925713
[TBL] [Abstract][Full Text] [Related]
6. Baseline characteristics and treatment response of patients from the Philippines in the CHIMES study.
Navarro JC; Gan HH; Lao AY; Baroque AC; Hiyadan JH; Chua CL; San Jose MC; Advincula JM; Lee CF; Bousser MG; Chen CL;
Int J Stroke; 2014 Oct; 9 Suppl A100():102-5. PubMed ID: 25041870
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors and Pattern of Long-Term Recovery with MLC601 (NeuroAiD™) in the Chinese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study.
Venketasubramanian N; Lee CF; Young SH; Tay SS; Umapathi T; Lao AY; Gan HH; Baroque Ii AC; Navarro JC; Chang HM; Advincula JM; Muengtaweepongsa S; Chan BP; Chua CL; Wijekoon N; de Silva HA; Hiyadan JH; Suwanwela NC; Wong KS; Poungvarin N; Eow GB; Chen CL;
Cerebrovasc Dis; 2017; 43(1-2):36-42. PubMed ID: 27846631
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and treatment effect in the CHIMES study.
Chankrachang S; Navarro JC; de Silva DA; Towanabut S; Chua CL; Lee CF; Venketasubramanian N; Wong KS; Bousser MG; Chen CL;
J Stroke Cerebrovasc Dis; 2015 Apr; 24(4):823-7. PubMed ID: 25680658
[TBL] [Abstract][Full Text] [Related]
9. Effects of MLC601 on early vascular events in patients after stroke: the CHIMES study.
Chen CL; Venketasubramanian N; Lee CF; Wong KS; Bousser MG;
Stroke; 2013 Dec; 44(12):3580-3. PubMed ID: 24135924
[TBL] [Abstract][Full Text] [Related]
10. Durability of the beneficial effect of MLC601 (NeuroAiD™) on functional recovery among stroke patients from the Philippines in the CHIMES and CHIMES-E studies.
Navarro JC; Chen CL; Lee CF; Gan HH; Lao AY; Baroque AC; Hiyadan JH; Chua CL; San Jose MC; Advincula JM; Venketasubramanian N;
Int J Stroke; 2017 Apr; 12(3):285-291. PubMed ID: 27784824
[TBL] [Abstract][Full Text] [Related]
11. The value of patient selection in demonstrating treatment effect in stroke recovery trials: lessons from the CHIMES study of MLC601 (NeuroAiD).
Venketasubramanian N; Lee CF; Wong KS; Chen CL
J Evid Based Med; 2015 Aug; 8(3):149-53. PubMed ID: 26291445
[TBL] [Abstract][Full Text] [Related]
12. Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study.
Venketasubramanian N; Moorakonda RB; Lu Q; Chen CLH;
Cerebrovasc Dis; 2020; 49(2):192-199. PubMed ID: 32126551
[TBL] [Abstract][Full Text] [Related]
13. Effect of Combined Treatment with MLC601 (NeuroAiDTM) and Rehabilitation on Post-Stroke Recovery: The CHIMES and CHIMES-E Studies.
Suwanwela NC; Chen CLH; Lee CF; Young SH; Tay SS; Umapathi T; Lao AY; Gan HH; Baroque Ii AC; Navarro JC; Chang HM; Advincula JM; Muengtaweepongsa S; Chan BPL; Chua CL; Wijekoon N; de Silva HA; Hiyadan JHB; Wong KSL; Poungvarin N; Eow GB; Venketasubramanian N;
Cerebrovasc Dis; 2018; 46(1-2):82-88. PubMed ID: 30184553
[TBL] [Abstract][Full Text] [Related]
14. Comparison Between the Original and Shortened Versions of the National Institutes of Health Stroke Scale in Ischemic Stroke Patients of Intermediate Severity.
Lee CF; Venketasubramanian N; Wong KS; Chen CL;
Stroke; 2016 Jan; 47(1):236-9. PubMed ID: 26628386
[TBL] [Abstract][Full Text] [Related]
15. Safety profile of MLC601 (Neuroaid) in acute ischemic stroke patients: A Singaporean substudy of the Chinese medicine neuroaid efficacy on stroke recovery study.
Young SH; Zhao Y; Koh A; Singh R; Chan BP; Chang HM; Venketasubramanian N; Chen C;
Cerebrovasc Dis; 2010; 30(1):1-6. PubMed ID: 20395679
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled, randomized phase II pilot study to investigate the potential efficacy of the traditional chinese medicine Neuroaid (MLC 601) in enhancing recovery after stroke (TIERS).
Kong KH; Wee SK; Ng CY; Chua K; Chan KF; Venketasubramanian N; Chen C
Cerebrovasc Dis; 2009; 28(5):514-21. PubMed ID: 19816018
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of MLC601 (NeuroAiD®), a traditional Chinese medicine, in poststroke recovery: a systematic review.
Siddiqui FJ; Venketasubramanian N; Chan ES; Chen C
Cerebrovasc Dis; 2013; 35 Suppl 1():8-17. PubMed ID: 23548914
[TBL] [Abstract][Full Text] [Related]
18. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
[TBL] [Abstract][Full Text] [Related]
19. NXY-059 for acute ischemic stroke.
Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase-5 Inhibitor PF-03049423 Effect on Stroke Recovery: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.
Di Cesare F; Mancuso J; Woodward P; Bednar MM; Loudon PT;
J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):642-9. PubMed ID: 26738812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
